IDG Contributor Network: Data sharing and medical research, fundraising is only the first step

Last week, Sean Parker (a founder of Facebook and, notoriously, Napster) announced the single largest donation to support immunotherapy cancer research. Totaling $250 million, the donation will support research to be conducted across six academic institutions, with the possibility of incorporating additional researchers if more funding is secured down the line.

I think it goes without saying that all donations to support medical research, particularly programs like immunotherapy that have a more difficult time receiving traditional funding, are fantastic.

However, a project like this isn’t just notable for the size of the donation, but also for the breadth of coordination that will be required to synthesize research across so many organizations. As past experience shows, innovating new models in research and discovery can be a challenge. For example, the now-defunct Prize4Life was founded to incentivize research into cures for ALS (Lou Gehrig’s disease). The organization was well funded and recognized for innovations such as a crowdsourcing approach to data science to try and foster breakthroughs. The data experiment failed however, and ultimately so did the organization.

More recently, Theranos has provided a cautionary tale for those looking to change processes without the strength of underlying data management and related quality standards. That company is perceived to have an execution problem, but what it really has is a data problem: trying to design testing that relies on the collection, analysis, and management of massive amounts of private data is a very ambitious undertaking.